Scribd
Upload
1K views

Drug Study Beta Blockers

This document summarizes information about a drug study, including: 1) The drug blocks stimulation of beta1-adrenergic (myocardial) and beta2-adrenergic (pulmonary, vascular, and uterine) receptor sites. 2) Therapeutic indications for the drug include angina pectoris, hypertension, prevention after myocardial infarction, and others. 3) Potential adverse effects include peripheral vasoconstriction, hypotension, bradycardia, arrhythmias, and heart failure.

Uploaded by

Dan Mandig
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
1K views

Drug Study Beta Blockers

This document summarizes information about a drug study, including: 1) The drug blocks stimulation of beta1-adrenergic (myocardial) and beta2-adrenergic (pulmonary, vascular, and uterine) receptor sites. 2) Therapeutic indications for the drug include angina pectoris, hypertension, prevention after myocardial infarction, and others. 3) Potential adverse effects include peripheral vasoconstriction, hypotension, bradycardia, arrhythmias, and heart failure.

Uploaded by

Dan Mandig
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Drug Study

Loule L Mallorca 8n4P


Carl uanlelle Mandlg
Mary Angela Margen

C|ass|f|cat|on Mechan|sm of Act|on Ind|cat|on Adverse Lffect Nurs|ng kespons|b|||t|es

8L1A ADkLNLkGIC 8LCCkLk


1herapeut|c Dose

O Anglna ecLorls Adu|ts 80
Lo 320 mg C dally ln
Lhree Lo four dlvlded doses
or 160 mg
O PyperLenslon Adu|ts 40
mg C bld or 80 mg
O rophylaxls afLer Ml
Adu|ts 180 Lo 240 mg C
dally ln Lhree Lo four
dlvlded doses
O ArrhyLhmlas Adu|ts 10 Lo
30 mg C
O PyperLrophlc CbsLrucLlve
CardlomyopaLhy Adu|ts
10 40 mg 3 or 4 Llmes a
day


8locks sLlmulaLlon of beLa1
adrenerglc
(myocardlal) and beLa2
adrenerglc
(pulmonary vascular and
uLerlne) recepLor
slLes




O Anglna ecLorls
O PyperLenslon
O rophylaxls afLer Ml
O ArrhyLhmlas
O PyperLrophlc CbsLrucLlve
CardlomyopaLhy


O erlpheral vasoconsLrlcLlon
O CrLhosLaLlc hypoLenslon
O 8radycardla
O ArrhyLhmlas
O PearL fallure
O Myocardlal lnfarcLlon and
sudden deaLh (wlLh
abrupL wlLhdrawal ln
anglna Lherapy)


O @ake aplcal pulse for 1 full
mlnuLe WlLhhold dose and
noLlfy prescrlber lf paLlenL has
bradycardla or Lachycardla
O Dse cauLlously wlLh renal or
hepaLlc lmpalrmenL slnus
node dysfuncLlon pulmonary
dlsease dlabeLes melllLus
hyperLhyroldlsm 8aynaud's
syndrome hyperLenslve
emergenclesmyasLhenla
gravls
O Advlse paLlenL Lo Lake wlLh
meals aL same Llme every day
Lo mlnlmlze Cl upseL
O CauLlon paLlenL noL Lo sLop
Laklng drug suddenly @ell hlm
dosage musL be Lapered
O lnform paLlenL LhaL drug may
cause muscle aches or bone
paln Advlse hlm Lo dlscuss
acLlvlLy recommendaLlons
and paln managemenL wlLh
prescrlber

You might also like